Anti-Factor Xa Activity of Standard and Japan-Specific Doses of Rivaroxaban in Thai Patients With Non-Valvular Atrial Fibrillation.

CONCLUSIONS: A significantly higher proportion of Thai patients receiving the Japan-specific dose of rivaroxaban had anti-FXa activity at peak concentrations within the expected range.
PMID: 32461505 [PubMed - as supplied by publisher]

Source: Circulation Journal - May 25, 2020 Category: Cardiology Authors: Wongcharoen W, Pacharasupa P, Norasetthada L, Gunaparn S, Phrommintikul A Tags: Circ J Source Type: research